TTrialPathMatch Me to Trials
← Back to trials
RecruitingIschemic Stroke

Gait Recovery in Patients After Acute Ischemic Stroke

Eligible age

18–80 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

More than 80% of ischemic stroke (IS) patients have some walking disability, which restricts their independence in the activities of daily living. Physical therapy (PT) significantly contributes to gait recovery in patients after IS. However, it remains unclear, what type of gait training is more effective and which factors may have impact on gait recovery. Two hundred fifty IS patients will be enrolled to undergo a 2-week intensive inpatient rehabilitation including randomly assigned robot-assisted treadmill gait training (RTGT) or therapist-assisted treadmill gait training (TTGT). A detailed clinical and laboratory assessment of gait quality, as well as the degree of neurological impairment, quality of life, cognition and depression will be performed in all patients during the study. We hypothesize that these variables may also affect gait recovery in patients after IS. In a randomly selected 60 enrolled patients, a multi-modal magnetic resonance imaging (MRI), including functional MRI, will be performed to assess neural correlates and additional predictors of gait recovery.

Sponsor: University Hospital Olomouc

You may qualify if…

  • Ischemic stroke detected on magnetic resonance imaging (MRI) with NIHSS score 1-12 points at the time of enrolment
  • Lower limb movement impairment with a score of at least 1 point on the NIH Stroke Scale (NIHSS) at the time of enrolment
  • Dependency in walking according to Functional Ambulatory Category (FAC) with score interval \<1,3\> (supervision or assistance, or both, must be given in performing walking)

You may not qualify if…

  • Previous history of any stroke, either ischemic or hemorrhagic
  • Other diseases modifying or limiting walking ability, currently receiving rehabilitation or participation in another study
  • Significant/symptomatic ischemic heart disease or significant/symptomatic peripheral arterial disease
  • Obesity (BMI ≥ 40), or weight higher than 110 kg (weight limit for the robot-assisted gait training)
  • Sensory aphasia with the inability to understand having been verified by a certified speech therapist.
  • Moderate or severe depression present at the time of enrolment assessed using the Beck scale, with a score above 10.
  • Known cognitive impairment
  • Previous disability or dependence in the daily activities assessed using the modified Rankin Scale with a score of 3 and more points

Source: ClinicalTrials.gov · NCT04824482 · last updated 2022-07-29